160 related articles for article (PubMed ID: 18344622)
1. C-reactive protein, left ventricular mass index, and risk of cardiovascular disease in essential hypertension.
Iwashima Y; Horio T; Kamide K; Rakugi H; Ogihara T; Kawano Y
Hypertens Res; 2007 Dec; 30(12):1177-85. PubMed ID: 18344622
[TBL] [Abstract][Full Text] [Related]
2. Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension.
Iwashima Y; Horio T; Kamide K; Rakugi H; Ogihara T; Kawano Y
Hypertension; 2006 Feb; 47(2):195-202. PubMed ID: 16380520
[TBL] [Abstract][Full Text] [Related]
3. Left Ventricular Structure and Risk of Cardiovascular Events: A Framingham Heart Study Cardiac Magnetic Resonance Study.
Tsao CW; Gona PN; Salton CJ; Chuang ML; Levy D; Manning WJ; O'Donnell CJ
J Am Heart Assoc; 2015 Sep; 4(9):e002188. PubMed ID: 26374295
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of left ventricular hypertrophy and changes in left ventricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan trial.
Yasuno S; Ueshima K; Oba K; Fujimoto A; Ogihara T; Saruta T; Nakao K
J Hypertens; 2009 Aug; 27(8):1705-12. PubMed ID: 19412127
[TBL] [Abstract][Full Text] [Related]
5. Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension.
Salles GF; Fiszman R; Cardoso CR; Muxfeldt ES
Hypertension; 2007 Oct; 50(4):723-8. PubMed ID: 17635853
[TBL] [Abstract][Full Text] [Related]
6. Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged ≥65 Years.
Leigh JA; O'Neal WT; Soliman EZ
Am J Cardiol; 2016 Jun; 117(11):1831-5. PubMed ID: 27067620
[TBL] [Abstract][Full Text] [Related]
7. Is left ventricular hypertrophy a low-level inflammatory state? A population-based cohort study.
Bo S; Mandrile C; Milanesio N; Pagani A; Gentile L; Gambino R; Villois P; Ghinamo L; Canil S; Durazzo M; Cassader M; Cavallo-Perin P
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):668-76. PubMed ID: 21429721
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy.
Yasunari K; Maeda K; Watanabe T; Nakamura M; Yoshikawa J; Asada A
J Am Coll Cardiol; 2004 Jun; 43(11):2116-23. PubMed ID: 15172423
[TBL] [Abstract][Full Text] [Related]
9. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.
Zoccali C; Benedetto FA; Mallamaci F; Tripepi G; Giacone G; Stancanelli B; Cataliotti A; Malatino LS
Kidney Int; 2004 Apr; 65(4):1492-8. PubMed ID: 15086493
[TBL] [Abstract][Full Text] [Related]
11. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
Kartal O; Inal V; Baysan O; Sağlam K
Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
[TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
14. Hematocrit and left ventricular mass: the Framingham Heart study.
Amin MG; Tighiouart H; Weiner DE; Stark PC; Griffith JL; MacLeod B; Salem DN; Sarnak MJ
J Am Coll Cardiol; 2004 Apr; 43(7):1276-82. PubMed ID: 15063442
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitive C-reactive protein as a potential indicator for predicting left ventricular hypertrophy in elderly community-dwelling patients with hypertension.
Song W; Zhang C; Tang J; Li Y; Jiao T; Lin X; Wang Y; Fang J; Sha J; Ding T; Cheng J; Li J
BMC Cardiovasc Disord; 2023 Sep; 23(1):480. PubMed ID: 37759159
[TBL] [Abstract][Full Text] [Related]
17. Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients.
Monfared A; Salari A; Kazemnezhad E; Lebadi M; Khosravi M; Mehrjardi NK; Rahimifar S; Amini N
Int Urol Nephrol; 2013 Dec; 45(6):1679-86. PubMed ID: 23306861
[TBL] [Abstract][Full Text] [Related]
18. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
[TBL] [Abstract][Full Text] [Related]
19. Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension.
Perticone F; Maio R; Ruberto C; Cassano S; Tripepi G; Perticone M; Sesti G; Zoccali C
Am J Kidney Dis; 2008 Jul; 52(1):74-84. PubMed ID: 18423813
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein and incident left ventricular hypertrophy in essential hypertension.
Assadi F
Pediatr Cardiol; 2007; 28(4):280-5. PubMed ID: 17563829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
